Compare iShares MSCI Indonesia ETF (EIDO) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs Manulife Financial Corporation — how do they compare? iShares MSCI Indonesia ETF trades at $12.22, while Manulife Financial Corporation trades at $43.22 (market cap $70.81B). The key difference: Manulife Financial Corporation pays a 3.1% dividend while iShares MSCI Indonesia ETF pays none, and Manulife Financial Corporation is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| EIDO | MFC | |
|---|---|---|
52-Week High | $19.22 | $43.07 |
52-Week Low | $10.80 | $29.90 |
Market Cap | — | $70.81B |
Sector | — | Financials |
Enterprise Value | — | $67.37B |
Dividend Yield | — | 3.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Indonesia ETF (EIDO) trades at $12.20, up 1.08% on the day, while technical indicators signal a bearish trend with moving averages and overall signals in sell territory. Recent news highlights Indonesia's economic initiatives, including a $15 billion AI-integrated free-meal program and central bank rate hikes to support the rupiah, which directly impacts this country-focused ETF. The fund's dividend was reported to have dropped 27% in 2025, raising questions about underlying asset performance.
The outlook for EIDO is tied to Indonesia's macroeconomic stability and government policy execution. Investment opportunity lies in exposure to Indonesia's growth initiatives, but risks include currency volatility from Bank Indonesia's defensive actions, geopolitical pressures on emerging markets, and the ETF's high-yield but potentially unstable dividend profile.
Manulife Financial (MFC) trades at $41.69, up 0.97% on the day and near its 52-week high, reflecting strong technical momentum. The company reported mixed Q1 2026 earnings but has beaten estimates in two of the last three quarters, with revenue growing to $53.01B in 2025. Analyst consensus is bullish with 8 Buy ratings and no Sell recommendations, supported by a solid 12.07% net income margin and 13.14% ROE. Recent news highlights AI advancements and a strong Asia business, though regulatory scrutiny on certain products presents a watch item.
The outlook for MFC is positive, driven by earnings growth in Asia, strategic AI investments, and a robust capital position. Key opportunities include expansion in wealth management and continued dividend returns. Primary risks involve regulatory pressures in Hong Kong, volatility in global wealth segments, and potential margin compression from competitive and macroeconomic forces.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
